Abstract Due to their transient nature, short-term exposures can be dicult to detect and quantify using conventional monitoring techniques. Biological monitoring may be capable of registering such exposures and may also be used to estimate important toxicological parameters. This paper investigates relationships between methanol concentrations in the blood, urine, and breath of volunteers exposed to methanol vapor at 800 ppm for periods of 0.5, 1, 2, and 8 h. The results indicate factors that must be considered for interpretation of the results of biological monitoring. For methanol, concentrations are not proportional to the exposure duration due to metabolic and other elimination processes that occur concurrently with the exposure. Firstorder clearance models can be used with blood, breath, or urine concentrations to estimate exposures if the time that has elapsed since the exposure and the model parameters are known. The 0.5 to 2-h periods of exposure were used to estimate the half-life of methanol. Blood data gave a half-life of 1X44 AE 0X33 h. Comparable but slightly more variable results were obtained using urine data corrected for voiding time 1X55 AE 0X67 h and breath data corrected for mucous membrane desorption 1X40 AE 0X38 h. Methanol concentrations in blood lagged some 15±30 min behind the termination of exposure, and concentrations in urine were further delayed.
Introduction
Exposure to many compounds can be detected and potentially quanti®ed using biological monitoring, i.e., the measurement of a target compound or a metabolite in breath, blood, urine, tissue, sweat, or saliva. Such monitoring may be used to estimate doses resulting from all exposure pathways, i.e., percutaneous absorption, inhalation, and ingestion (Murthy and Halperin 1995) , and to advance knowledge related to the absorption, distribution, and elimination of chemicals in the body (Droz and Fiserova-Bergerova 1992) . Many health standards include criteria for both short-and long-term exposure to airborne contaminants so as to re¯ect the health signi®cance of the accumulated dose and the dose rate, and biological monitoring may be used to evaluate exposure to many contaminants. For example, the threshold limit values include both 15-min (TLV-STEL) and 8-h (TLV-TWA) air concentrations, which for methanol are 250 and 200 ppm (310 and 260 mg/m 3 ), respectively, and the biological exposure index (BEI) corresponding to the TLV-TWA is a methanol concentration of 15 mg/l urine (ACGIH 1991).
Transient exposures, which may cause high dose rates, can be both dicult and costly to monitor (Rappaport and Spear 1988) . Many exposures in the workplace and elsewhere can be considered transient, a result of changes in factors such as chemical emissions, ventilation, and worker movement. Moreover, shortterm high-concentration exposures may involve physiological mechanisms somewhat or very dierent from those of long-term exposures, with the possibility that the biologically eective dose is not proportional to the exposure time or concentration, in contrast to conventional assumptions. For example, high levels of exposure may saturate certain metabolic pathways (Kavet and Nauss 1990; Droz and Fiserova-Bergerova 1992) , and the absorption of solvents in the mucous membrane of the respiratory tract may aect the kinetics and uptake of water-soluble vapors (Franzblau et al. 1995; Kumagai and Matsunaga 1995) . Biological monitoring may be used to estimate the eective dose, partially or fully defusing the biological issues related to uptake, redistribution, and metabolism as well as the practical diculties of measuring concentrations with high time resolution.
This paper presents results from an experimental study of methanol exposure that examines responses seen in blood, breath, and urine samples collected from subjects exposed to methanol vapor at 800 ppm for periods ranging from 30 min to 8 h. The study investigates clearance, the relationship between exposure duration, dose, and uptake rate, and the eectiveness of breath, blood, and urine measurements as BEIs. This is the ®rst study to examine the relationship of blood, urine, and breath samples to controlled inhalation exposures to methanol of varying duration. A concentration above the TLV is used that may be relevant to both occupational and nonoccupational settings where intermittent and uncontrolled exposure can occur.
Methanol is a widely used solvent and potential motor vehicle fuel, and workplace exposures have resulted in cases of acute toxicity (Kavet and Nauss 1990) . A number of experimental and ®eld studies have addressed the relationship between inhalation exposures to methanol and biological indicators, including methanol and formate in end-shift urine and methanol in blood (e.g., Leaf and Zatman 1952; Sedivec et al. 1981; Kawai et al. 1991 Kawai et al. , 1992 Franzblau et al. 1992b Franzblau et al. , 1997 Yasugi et al. 1992) as well as breath monitoring (Lee et al. 1992; Franzblau et al. 1992a Franzblau et al. , 1995 . Methanol readily passes into and through the skin, and the role of the dermal exposure pathway has been demonstrated in several reports (Dutkiewicz et al. 1980; Franzblau et al. 1995; Batterman et al. 1996a; Batterman and Franzblau 1997) . The pharmocokinetic models needed to interpret biological monitoring of methanol are largely generic, but models speci®c to methanol have been formulated (Horton et al. 1992; Perkins et al. 1995) . The data described herein have not previously been presented, although many experimental details are shared in related studies by the authors (e.g., Franzblau et al. 1995 Franzblau et al. , 1997 Batterman et al. 1996a,b; Batterman and Franzblau 1997) .
Materials and methods

Inhalation exposures
The exposure protocol consisted of separate sessions for each subject, scheduled at least 1 week apart. Each of the four core subjects stayed in the exposure chamber for 30, 60, and 120 min, and each repeated the session a second time (and a third time in the case of one subject in the 120-min exposure). Thus, the total shortterm sample consisted of 3 exposure durations´4 subjects´re-plicates +1 additional replicate 25 sessions. In addition, 15 sessions of 8-h duration and 12 sessions as controls were conducted. The 8-h exposures included dierent (noncore) subjects, some of whom also participated in the control exposures. Similar procedures were followed in each session, including controls, although the timing of collection of some samples varied slightly as described below.
Exposures were conducted in a 47-m 3 stainless-steel exposure chamber containing a suspended¯oor and ceiling, a restroom, and an airlock entry. The chamber was maintained at 50% relative humidity and 22°C and was ventilated at 18 chamber volumes/h with air ®ltered for particulate and gaseous contaminants. Methanol vapor was introduced via a two-stage vapor generator and metered into the ventilation air¯ow using a mass¯ow controller to achieve the desired concentration of 800 ppm. A dedicated MIR-AN 1-A (Foxboro Co., Foxboro, MA) infrared analyzer continuously monitored chamber air in each session. Concentrations were maintained within $1% of the target concentration.
Breath sampling and analysis
Two breath samples were collected at $10 and $15 min before each short-term exposure session. Breath samples were collected at 0, 15, 30, and 45 min, as well as 1, 1.5, 2, 3, 4, 5, 6, 7, and 8 h after departure from the exposure chamber in the 30-min duration and control sessions. A similar schedule was followed for the longerexposure sessions, but to keep the sessions' length to 8 or 9 h, the ®nal sample and the last two samples were eliminated for 1-and 2-h exposures, respectively. In the 8-h exposure, single breath samples were collected prior to exposure, immediately upon departure from the exposure chamber, and at 5, 10, and 15-min thereafter.
Breath samples were collected using a breath maneuver and sampling system that captured alveolar air in 0.5 l aluminized Mylar gas-sampling bags (Quintron Instrument Co., Milwaukee, Wis.). The gas-sampling bags were analyzed for methanol and carbon dioxide (CO 2 ) using Fourier transform infrared (FTIR) analysis within 1 day of sampling. CO 2 measurements were taken to ensure that breath samples represented alveolar air. After warming of the sampling bag the sample was transferred to an evacuated 5-m path-length gas cell of a Bomem MB-100a (Montreal, Canada) FTIR spectrometer equipped with a mercury-cadmium-telluride (MCT) nitrogen-cooled detector. Cell pressure was maintained at 500 mmHg to avoid sample condensation. IR spectra were collected at 2 cm A1 resolution using 32 scans and were ®tted using an ordinary least-squares procedure and reference spectra, e.g., 2% CO 2 in N 2 (Scotts Specialty Gases, Troy, Mich.) and 50 and 1000 ppm methanol in N 2 . The limit of detection (LOD) for methanol was $0.5 ppm, and the coecient of variation (COV) was $2%.
Blood sampling and analysis
Blood samples were collected at 0, 15, and 30 min as well as 1, 2, 3, 4, 5, 6, and 7 h following exposure in the short-term and control sessions and at 6 and 8 h into the 8-h duration session. The 7-h sample was omitted in the 2-h exposure session. Two samples were also collected prior to exposure. Blood was drawn from the subject's arm into a``gray top'' Vacutainer tube (containing potassium oxalate and sodium¯uoride), which was immediately refrigerated. Methanol concentrations were determined for two replicates of each blood sample using head-space gas chromatography and ame ionization detection. For these measurements the LOD was $0.5 mg/l and COVs were 3±5%.
Urine sampling and analysis
All voided specimens were collected by subjects in standard hospital-collection containers and were immediately measured for volume and speci®c gravity by refractometry. Void specimens were requested prior to the exposure and at the end of the session. Otherwise, spontaneous voids were collected. Aliquots were stored at 4°C for later analyses of methanol using head-space gas chromatography. LODs recorded for methanol in urine were below 0.5 mg/l.
Study population
The core subjects consisted of four women aged 41±63 years who participated in all short-term exposure sessions. The same four women, plus eight others, participated in the control sessions. In all, 3 other women and 12 men participated in the 8-h session. Subjects were at rest during the exposure and were permitted to eat and drink freely during the experiment with the exception of alcoholic beverages during the session and the preceding 24 h. None of the subjects had known occupational or avocational exposure to methanol, formic acid, or formaldehyde, and none smoked. The subjects provided written informed consent using forms and protocols approved by the University of Michigan School of Public Health and the General Motors Research & Development Center.
Data analysis
Collected data were analyzed as follows. Breath concentrations were screened by elimination of the few (<1%) observations in which CO 2 levels fell below $3%, indicating nonalveolar air. Baseline or preexposure concentrations were computed for each subject by averaging of observations made prior to entry into the exposure chamber. Descriptive statistics (means, standard deviations, maxima) were computed for each session and across sessions, the latter by averaging of observations across subjects and sessions at the same exposure time. Across-session urine data were somewhat more complicated to analyze due to the irregular sampling schedule. Across-session averages were estimated as the average of void specimens grouped to the nearest hour.
A ®rst-order clearance model was used to ®t observation g t (mg/l for blood and urine; ppm for breath) collected at time t (h) following exposure (Droz and Fiserova-Bergerova 1992) :
where g is an initial (intercept) concentration, k is the rate constant (h
A1
), and g is the baseline concentration or endogenous level as determined using preexposure data. To aid interpretation, k is expressed as a half-life s (h) such that s 0X693ak. Parameters g and s, associated standard errors, and model-®t 2 were estimated for methanol concentrations in blood, urine, and breath for each shortterm exposure session. To avoid bias of the half-life estimate, parameters for the urine data were estimated using midinterval voiding times (Droz and Fiserova-Bergerova 1992) . Data that clearly did not ®t a ®rst-order decay were omitted, e.g., concentrations that continued to rise immediately after exposure ceased, and consecutive observations clearly rising long after exposure ceased. Data falling below detection limits were also omitted. First-order models were not estimated for the 8-h sessions because samples were collected only 15 min following the end of the exposure, an insucient duration for estimation of model parameters.
Postexposure breath data were also ®tted to a multicompartmental linear model (Droz and Fiserova-Bergerova 1992) :
where g Yi and k i represent the intercept (ppm) and rate constant (h
), respectively, of the ith ®rst-order process or compartment. Double-and triple-compartmental models (n 2 and n 3, respectively) were considered. Model parameters were estimated using a forward-dierence quasi-Newton method. Although such models have been used to represent breath concentrations and mass balances for four compartments, i.e., blood, vessel-rich tissues, vessel-poor tissues, and fat (Wallace and Pellizzari 1995) , the compartments may not relate to speci®c physiological variables. In the present case this approach is primarily used to determine times when breath sampling will re¯ect concentrations in blood. If the processes in Eq. 2 are independent, then the total methanol released from the ith compartment is the integral of (2) from t 0 to t I or g Yi ak i and the fraction of the total methanol released in breath by the jth compartment, f j , is:
These fractions apportion the contribution of each compartment.
Concentrations in blood were used to estimate the accumulated dose and uptake rates. Another solution of the ®rst-order model was used to estimate the methanol uptake rate in blood occurring during the exposure e (mg/h):
where g 0 is the concentration in blood reached immediately after departure from the exposure chamber, is the volume of bodȳ uids ($42 l for the subjects in the study), k is the rate constant previously determined for blood, and t e is the duration of the exposure (h). This approach assumes ®rst-order clearance, a constant uptake rate during the exposure, and rapid and uniform partitioning of methanol between blood and other body¯uids. Because blood concentrations continued to increase for 15 or 30 min after exposure had ceased, possibly from desorption of methanol from the mucous membrane into the airways or due to redistribution in body compartments, a post-exposure uptake rate term pe1 (mg/h) was estimated by combination of Eqs. 1 and 4:
where g 15 is the concentration observed at 15-min (0.25 h) after the exposure had terminated. The postexposure uptake rate pe1 is assumed to be constant during the short (15-min) period considered: thus, pe1 approximates the average uptake over the 15-min period. Note that pe1 may be much smaller than e , the uptake rate during the exposure, and pe1 may decline rapidly over the short period considered. A similar postexposure uptake rate, pe2 , was estimated for the 15-to 30-min period. No uptake was found at postexposure times beyond 30 min. The total uptake of methanol absorbed over the session, w total (mg), was estimated as:
where t e is the exposure duration (h). Uptake rates were estimated for the 0.5-, 1-, and 2-h periods of exposure where frequent blood sampling was available.
Results Table 1 summarizes results obtained in blood, urine, and breath samples at each exposure duration and lists the baseline or preexposure concentrations, maximal concentrations above baseline, and concentrations above baseline obtained at 15 min following exposure for blood and breath (as urine voids were spontaneous, this result was not obtained). These concentrations are averaged across subjects and replicates. The sample size for the control (no exposure) used 12 exposure sessions, 4 of which involved the core subjects; the 0.5-to 2-h exposures used the 4 core subjects with 2±3 replicates each; and the 8-h exposures used 15 sessions (involving noncore subjects). No systematic bias was noted between core and noncore subjects. Table 1 also shows the half-life and intercept statistics from ®rst-order models, discussed below.
Blood data
Baseline or endogenous concentrations of methanol in blood averaged 1.8 0.7 mg/l and showed no trend by subject or exposure duration. Subjects with elevated baseline levels often maintained a dierential over the session, e.g., the single highest baseline measurement (3.4 mg/l) recorded for one subject was similar 8 h later, well after most methanol from the inhalation exposure would have cleared. Baseline concentrations were small in comparison with levels found for 1-h or longer periods of exposure, and also with the 15-mg/l BEI reported for methanol in urine (ACGIH 1991) . (Blood:urine partition coecients are near unity.) Figure 1 shows trends observed in methanol concentrations in blood for 0.5-, 1-and 2-h exposure sessions. Means across the eight or nine sessions, corrected (by subtraction) for preexposure methanol levels, are plotted. Parameters of the ®rst-order model (Eq. 1) for Table 1 and predictions are plotted in Fig. 1 . Samples collected at postexposure times of 0 and 15 min were not used to ®t these models due to the lag in the maximal concentrations, clearly seen in the 30-min duration exposure and, to a lesser extent, in the session data recorded for longer exposures.
In the 30-min exposures, a delay in maxima was seen in six of eight sessions. With the exception of the samples collected at postexposure times of 0, 15, or 30 min, the ®rst-order models provided an excellent ®t. Across all exposure durations and sessions the half-life averaged 1.44 0.33 h and the 2 exceeded 0.95. Models for individual sessions showed good ®ts ( 2 ! 0X92; mean 2 0X98) and no signi®cant dierence between subjects or exposure times, although results noted for individual sessions and subjects could be variable, e.g., one subject had half-lives ranging from 1.01 to 2.38 h. This variability can occur due to subject variability, endogenous methanol production, and experimental errors, including baseline estimates. Relative measurement errors increased at the low methanol concentrations that resulted from short-duration exposures when uptake was small and at long postexposure times after substantial clearance. As discussed above, half-life estimates excluded some data, primarily initial points if maxima were not reached and tailing points if increases were detected. Although data omissions aected some session results, eects were small on averaged data. Most half-life estimates had low levels of uncertainty, and few data were excluded. Table 1 also lists estimates obtained for the maximal methanol level using the ®rst-order model at t 0, i.e., the model intercept g , corrected for baseline g . Intercepts slightly exceeded observed maxima, possibly representing a departure from the ®rst-order model, noninstantaneous uptake, or a time lag for the redistribution of methanol.
Levels of methanol in blood predicted using the ®rst-order model and the estimated 1.44-hr half-life show that concentrations do not increase linearly with exposure duration but asymptotically approach the steadystate level reached after many hours of exposure. For 0.5-, 1-, 2-, and 8-h exposure periods, maxima should reach 21%, 38%, 62%, and 98% of the steady-state level, respectively. Experimental results show that doubling of the exposure duration from 1 to 2 h approximately doubled concentrations (from 6.6 1.2 to 14.0 1.5 mg/l), but quadrupling of the duration from 2 to 8 h only doubled methanol concentrations (to 30.7 6.9 mg/l). These results are in general agreement with predictions.
Urine data
The analysis of the urine data parallels that for the blood data. The results are summarized in Table 1 , and observed mean values and predictions are plotted in Fig. 2 . In contrast to blood data, urine data have greater variability, in part due to the smaller sample size (n 3±7 samples, including preexposure samples) as compared with blood data (11 samples) and to the variation in voiding times following exposure. However, Figs. 1 and 2 illustrate that methanol concentrations in urine and blood agree at intermediate times following exposure.
Baseline concentrations in urine were generally small, averaging 1.3 0.8 mg/l. As observed for the blood data, elevated baselines were often maintained over the 8-to 9-h duration sessions. Maximal concentrations increased with exposure time, although trends seen for individual sessions were sometimes inconsistent until the exposure duration reached 2 h. The average concentrations across individuals and replicates increased monotonically, but some increases were small, e.g., from 3.2 1.2 to only 4.0 1.4 mg/l for 0.5-and 1-h periods of exposure, respectively. As compared with the 1-hr exposure, concentrations increased 3-fold for the 2-h exposure (11.0 3.2 mg/l) and 7-fold for the 8-h exposure (74 33 mg/l). The 8-h exposure yielded urinary concentrations 23% higher than that expected by scaling of the ACGIH BEI from 15 mg/l for a 200-ppm 8-h exposure to 60 mg/l for a 800-ppm 8-h exposure.
Urinary methanol levels closely ®t ®rst-order models and most sessions had 2 ! 0X9. Model intercepts for individual sessions showed moderate variation, a result of the few data points available and the need for a 2-h extrapolation in most cases, i.e., spontaneous voids were generally collected several hours after departure from the exposure chamber. (No such extrapolation was needed for blood since samples were collected immediately upon exit from the chamber.) Model intercepts exceeded maxima, especially for the 0.5-and 1-h exposures. These predictions represent concentrations in ur- ine at the time of the peak methanol concentration in blood. Since the corresponding void samples were generally unavailable, predictions cannot be veri®ed. However, predicted levels (5.8, 6.4, and 13.0 mg/l for 0.5, 1-and 2-h durations, respectively) closely matched maxima in blood (5.3, 6.6, and 14.0 mg/l, respectively). At equilibrium, methanol concentrations in blood and urine should be similar, although blood concentrations will be slightly lower due to its higher lipid content.
Half-life estimates based on urine data were comparable with those based on blood samples, though levels of uncertainty were higher, particularly for the shortduration exposures, where analytical uncertainties and errors in baseline estimates may have obscured increments due to the inhalation exposure.
Breath data
Methanol concentrations in breath are summarized in Tables 1 and 2 and plotted in Fig. 3 . Data collected at 0, 5, and 10 min after exit from the chamber are not plotted, as they would be o-scale. Baseline levels of methanol in breath were low (0.4 0.6 ppm).
The highest methanol concentrations were measured immediately after departure from the exposure chamber. Mean concentrations ranged from 140 to 187 ppm (109 to 205 ppm for individual sessions), and no relationship to exposure duration was observed. Concentrations declined rapidly after exit from the chamber ( Table 2) . As discussed by Franzblau et al. (1995) , Kumagai and Matsunaga (1995) , and other investigators, concentrations of water-soluble compounds such as methanol in breath samples can re¯ect concentrations in the liquid ®lm surrounding the mucous membranes rather than alveolar air. Because these breath concentrations did not vary with exposure time, the mucous membrane, or at least its outer ®lm in contact with the chamber air, was apparently``saturated'' with methanol at all tested exposure durations. Concentrations in breath recorded immediately after exposure (averaging 160 30 ppm) were well below the chamber concentration (800 ppm). At 15 min after exposure, concentrations in breath were much lower as the mucous membranes had apparently desorbed the``excess'' methanol. Breath concentrations noted at a postexposure time of 15 min showed monotonic increases with exposure duration, though the increase observed from 30-min to 1-h exposures was small (from 4.0 0.8 to 4.8 1.2 ppm), as was the increase seen from 2-to 8-h exposures from (7.1 2.4 to 7.6 1.7 ppm). In contrast, methanol in blood doubled in the 1-to 2-h exposures and also in the 2-to 8-h exposures. The similar concentrations observed in breath suggest that desorption from the mucous membranes was incomplete at a postexposure time of 15 min. The multicompartmental models, discussed below, con®rm these trends. First-order models were estimated using breath samples collected at 15 min to 6 h after departure from the exposure chamber (Fig. 3) . Model ®ts were high (0X89 2 0X96). The mean estimated half-life (1.38 0.86 h) was slightly shorter than that found using blood or urine data. On omission of the data from e.g., 0±30 min, 0±1 h, and 0±2 h, half-life estimates considerably lengthened, apparently a result of exclusion of the desorption processes. Again, the multicompartmental models provide a way to address these changes (artifacts) in the half-life estimated from breath data.
Comparison of blood and breath data Table 2 lists the average concentrations of methanol observed in blood and breath and those predicted in breath using two blood:air partition coecients: 2874 (Pezzagno et al. 1983 ) and 1518 (Fiserova-Bergerova and Diaz 1986). For postexposure times of less than $1 h, observed concentrations in breath exceeded predictions, indicating that concentrations detected in breath were not in equilibrium with those found in blood. Dierences were small at post-exposure times of 0.5±1 h. In contrast to previous work, where the larger partition coecient was found to provide a good ®t to breath samples in subjects with dermal exposure (Franzblau et al. 1995) , the smaller coecient appears more accurate. The next section con®rms that $0.5 h is needed for full desorption of methanol from the upper respiratory tract.
Multicompartmental models for breath data
Parameters of three-compartment models calibrated for the breath data are shown in Table 3 . Two-compartment models poorly ®t the 5-and 10-min postexposure observations. Three-compartment models provided an excellent ®t ( 2 ! 0X99 and low relative errors). The ®rst compartment has a short half-life (0.25±1.2 min), a high initial concentration (103±151 ppm), and accounts for 4±39% of the exhaled methanol. The second compartment has an intermediate half-life (3.7±7.5 min) and a moderate initial concentration (8.2±44 ppm). These compartments may re¯ect fast and slow desorption processes from the mucous membranes. The third compartment had the slowest release rate (half-life 0.99± 1.74 h) and a low initial concentration (2±5.1 ppm), slightly below the concentrations measured at 15 min after exposure or estimated as the model intercept (Table 4). The half-life for this compartment averaged 1.40 0.38 h, similar to that estimated using blood or urine. The third compartment re¯ects end-expired or alveolar air, which should be in equilibrium with blood. Although the short-term compartments contributed a minor fraction of the total methanol exhaled, particularly at longer exposure durations, concentrations due to the short-term compartments were much higher, albeit brie¯y, than levels in alveolar air. Table 4 shows the combined contribution of the two short-term compartments to the total breath concentration (resulting from all three compartments). For example, short-term processes account for 56% of the methanol in a breath sample taken at 15 min after a 30-min, 800-ppm exposure, meaning that breath sampling will overestimate concentrations in blood by a factor of 2. As blood concentrations increase with longer exposure times, these contributions will decrease. For 1-and 2-h exposures, short-term processes contribute 45% and 36%, respectively, of methanol concentrations at 15 min. Eects on 8-h exposures are estimated in Table 4 using parameters of the 2-h model, except that the intercept of the third compartment is set to 11.2 mg/l, scaled from the 2-h data using 2-and 8-h concentrations in blood. For an 8-h exposure, short-term processes account for 21% of methanol at 15 min. Additional time reduces the contributions of the short-term processes. Assuming that 5% contributions are acceptable, $30 min in a methanol-free environment is required, and somewhat less time is needed for longer periods of exposure.
Methanol uptake rates and doses Table 5 lists the uptake rates and doses estimated using the blood data and Eqs. 4±6. The uptake rate e found for the short-term exposures, 346 to 448 mg/h, was substantially below the 587-mg/h rate noted for the 8-h exposures. Uptake into blood continued for 15 min after the termination of exposure, with the average rate being 131 76 mg/h. Some uptake appeared to continue in the 15-to 30-min postexposure period, but results were inconsistent. The contribution of postexposure uptake is indicated in the lower portion of Table 5 . Post-exposure uptake accounts for 10% of the total uptake in the 30-min exposures and for 5±6% in the 1-and 2-h exposures.
The higher uptake rates recorded for the 8-h exposures may be attributable to dierences in the study population. The 8-h exposures used a group that was younger (38 14 versus 54 4 years), taller (177 8 versus 166 1 cm), slightly heavier (79 18 versus 78 13 kg), more numerous (15 versus 4 subjects), and predominantly male (80% men versus 100% women). In addition, the clearance of methanol may have been slower in the 8-h exposure group due to (partial) metabolic saturation. If so, the use of the 1.44-h half-life, which would be incorrect at that exposure level, would increase the apparent uptake rate. Thus, although subjects in the 0.5-to 2-h exposures were identical and their results are comparable, they should not be compared with the uptake rates noted for the 8-h exposure group.
Discussion
Interpretation of breath samples
Although it is the easiest of the three BEIs to sample and analyze, the interpretation of breath samples is complicated by the uptake and release of methanol in the moist surfaces and, possibly, deeper layers within the head airways and tracheobronchial regions. Many anatomical, physiological, and chemical factors can in¯uence the uptake and retention of water-soluble vapors, including mouth versus nose breathing, solubility and diusion rates of the vapor, airway dimensions, and respiratory characteristics, e.g.,¯ow rate. Most surfaces in the head airways and tracheobronchial regions are covered by a thin mucous layer. The respiratory bronchioles, far down in the respiratory tract just above the alveolar Table 5 Methanol uptake rates and total methanol uptake estimated using blood data and ®rst-order models ( e denotes uptake during the exposure period, pe1 and pe2 apparent uptake into blood during the postexposure periods indicated, NA no blood measurement taken) ducts and tracts, contribute by far the greatest surface area of mucus lined surfaces, 7.5 m 2 as compared with 0.047 m 2 in the head airways region (including the larynx and esophagus), 0.03 m 2 in the trachea and bronchi, and 0.26 m 2 in the bronchioles (ICRP 1994) . Walls of the respiratory bronchioles consist of a 5-to 10-lmthick mucous membrane (Johanson 1991), a single-layer respiratory epithelium of cuboidal cells, and smoothmuscle layers. The much larger 140-m 2 area of the alveolar ducts and sacs consists of squamous alveolar cells without a mucous layer.
The multicompartmental model, an empirical approach to deal with a complex physiological process, suggests fast and slow release processes for the head airways and tracheobronchial regions. The mucous membranes are not homogeneous, however, and`d esorption'' may also re¯ect diusion through a liquid ®lm covering the mucous membrane or through cells, a process that is not expected to be of the ®rst order. The fastest compartment (half-life 0.64 0.47 min) may re¯ect the outermost layers of the mucous membrane that achieves near-instantaneous equilibrium with air. The second compartment (half-life 5.0 2.1 min) may re¯ect deeper layers of the respiratory system in¯uenced by nonequilibrium processes such as diusion. To provide more insight into these compartments we conducted several simulations using a time-varying diusion model. Many aspects of the data could be reproduced by modeling of uptake in a homogeneous sheet representing the moist surfaces and deeper layers within the head airways and tracheobronchial regions. Methanol uptake and release from one side of the sheet in equilibrium with methanol vapor was modeled. The sheet's opposite side was impermeable. The observed kinetics could be approximated using a sheet thickness of 0.12 cm (a ®tted parameter), a diusion coecient of 10 A5 cm 2 /s (an approximate value for methanol in mucus or water), and an arbitrary concentration-area product scaled to match the data (a second ®tted parameter). The sheet thickness and diusion coecient determines the dynamics. Although the concentration-area product could not be justi®ed, the thickness implies penetration of methanol well beyond the $10-lm ®lm that coats the airways. While simplistic, the model suggests that the physical dimension of the process is larger than the very thin mucous membrane ®lm. However, lags in desorption processes also could result from poorly ventilated`d ead'' spaces or for other reasons.
Estimates of postexposure uptake (Table 5 ) from the desorption of solvent from the mucous membranes or some other reservoir are preliminary. The time resolution of blood sampling (15 min) imperfectly captures the fast desorption kinetics (half-lives 0.6 and 5 min), and the small sample size and experimental errors contribute additional uncertainties. Nonetheless, a delay in maxima was seen in most of the 30-min exposure sessions. Additional evidence that mucous membranes represent a reservoir is shown by breath concentrations of 100± 200 ppm measured upon exit from the exposure chamber and by concentrations that remained elevated for 15±30 min. For the shortest exposures tested this reservoir probably contributed no more than 10% of the total uptake. For exposures exceeding $1±2 h, its eect appears negligible. This reservoir may be important for brief exposure to water-soluble vapors, where it increases uptake.
Several physiologically based models take into account the absorption of solvents in the mucous membrane of the respiratory tract, including nasal uptake of solvents (Gerde and Dahl et al. 1991; Morris et al. 1993) , uptake of solvents in the wall of the respiratory tract (Johanson 1991) , and the kinetics of the mucous layer (Kumagai and Matsunaga 1995) . Kumagia and Matsunaga (1995) considered only the outermost layer ($1± 5 lm thick) of the mucous membrane and a $0.5-m 2 region above the terminal bronchioles, giving a mucous volume of 0.5±2.5 cm 3 . This layer was assumed to act as a single compartment in equilibrium with vapor concentrations and, thus, had a very fast time constant. Although other models that do not incorporate a mucous membrane reservoir have successfully simulated inhalation exposure to methanol (e.g., Horton et al. 1992 ), these models were not utilized for short-term exposure, nor were suciently frequent blood measurements taken to observe the reservoir eect. Additional work is needed to con®rm the reservoir eect, possibly using yet shorter periods of exposure and more frequent blood sampling.
It is clear that exposure and half-life estimates of water-soluble compounds should not be based on breath samples collected soon after a potential inhalation exposure. The equilibrium and multicompartmental models indicate that short-term processes, e.g., desorption, can dominate concentrations measured in breath. For methanol, at least 30 min is needed for breath samples to re¯ect alveolar air that is largely ($95%) free of solvent absorbed elsewhere in the respiratory system. This is longer than the 15 min we previously estimated (Franzblau et al. 1995) using 8-h exposure sessions. The short periods of exposure used in the present study provided better opportunities to evaluate breath monitoring as a BEI.
Lung retention Sedivec et al. (1981) and other investigators calculate the lung retention by the dierence in concentrations measured between inspired and expired air divided by the concentration detected in inspired air. Using averages, a 79% lung retention factor is calculated from the reported data as compared with the 58% value found by Sedivec et al. (1981) and the 65±74% value found by our co-workers (Lee et al. 1992 ). Sedivec et al.'s results dier because we employed a breath-sampling maneuver designed to expel air from deep within the lungs, and the sampling apparatus excluded the ®rst 0.5 l of breath exhaled. Both steps were designed to exclude air from the tracheobronchial``dead space,'' where methanol concentrations may approach the chamber concentration, and to sample alveolar air, where concentrations should be much lower and re¯ect equilibrium with levels in blood.
Clearance
Methanol is excreted unchanged in urine and exhaled breath and is metabolized primarily in the liver. Because methanol's toxic acute properties are linked to intermediate metabolites, not the alcohol itself, the kinetics of the metabolic process are important (Kavet and Nauss 1990) . Faster clearance of methanol would imply more rapid and severe formate generation and acidosis, as well as potentially greater acute toxicity. Several studies in humans have examined clearance (see the review of Kavet and Nauss 1990) . Using oral exposure in three volunteers and urine sampling, Leaf and Zatman (1952) estimated that methanol disappearance followed ®rst-order kinetics with a half-life of $3 h. Using 8-h inhalation exposure, four volunteers, and urine sampling, Sedivec et al. (1981) estimated a half-life of 1.5± 2 hr. Examining end-shift urine samples on occupational inhalation exposure and also earlier dermal exposure studies, Kawai et al. (1991) estimated a half-life of 7±8 h. The half-life estimates reported herein, i.e., 1.44 0.33 h in blood, 1.55 0.67 h in urine, and 1.40 0.38 h in breath (from the multicompartmental model) are consistent with those found by Sedivec et al. (1981) . Leaf and Zatman's (1952) work may not be representative since oral exposure may involve a reservoir eect in the gastro-intestinal tract that increases the apparent half-life, and their results are based on only two subjects. Kawai et al.'s (1991) estimate is based on ®eld conditions without controls on exposures, and it has the possibility of interferences. Laboratory studies should be free of these concerns. Dermal exposures also involve additional reservoirs and buers that can bias half-life estimates (Batterman and Franzblau 1997) . Note that the clearance of methanol can be much slower following high doses, i.e., the methanol half-life is $1 day for doses exceeding 1 g/kg (Kavet and Nauss 1990) , and non-®rst-order kinetics (e.g., using the MichaelisMenton equation) may be needed to describe elimination (Droz and Fiserova-Bergerova 1992; Perkins et al. 1995) . Such doses far exceed those used in the present study.
Half-life estimates based on blood, urine, and breath samples were comparable. Blood data had lower levels of uncertainty and may be somewhat more accurate since the time of collection can be accurately determined. In contrast, the urine samples represent time-weighted averages that require correction to the midinterval voiding time. Thus, postexposure or end-shift urine sampling seems unlikely to accurately re¯ect transient exposure. Breath samples are more dicult to interpret. Because desorption processes tend to cause very high initial concentrations, estimates of clearance or dose from breath samples must either use multicompartmental models or exclude data potentially aected, e.g., the ®rst 30 min following an air exposure.
Evaluation of biological monitoring for short-term exposures
The ability to quantify short-term inhalation exposure can be a rigorous test of a biological measurement, and the results of this study demonstrate several strengths and weaknesses of urine, blood, and breath measurements. In the 2-h 800-ppm exposure, which is equivalent to the concentration-time product of the TLV-TWA, the concentration of methanol in urine averaged 11 mg/l, below the BEI (15 mg/l), and the peak lagged the termination of exposure by several hours. Soon after the exposure, blood concentrations averaged 14 mg/l, close to the BEI. In practice, it is dicult to collect blood samples, especially after a short-duration exposure. Furthermore, the relationship between the exposure period and the concentration of biological samples is not expected to be linear unless clearance is slow relative to the exposure duration. If the partition coecient is known, then doses can be derived from breath samples; however, breath sampling must occur at least 30 min after inhalation to allow sucient desorption of solvent from the mucous membranes.
Measurements in breath, urine, and blood taken during and after short-term inhalation exposure can be used to estimate the dose received by an individual, given that the elapsed time since the exposure and ®rst-order corrections are made using appropriate methods. However, signi®cant errors may result in quanti®cation of the dose if exposures are transient and their timing is unknown. Nonetheless, because they incorporate the eects of physiological factors that aect the uptake and clearance of toxicants among individuals as well as the dermal exposure pathway, biological measurements oer advantages in comparison with area and environmental monitoring. The limitations of biological monitoring must also be viewed with respect to the feasibility and cost of monitoring of breathing-zone air.
In conclusion the experimental results showed consistent patterns with regard to the methanol concentrations detected in breath, urine, and blood following short-term inhalation exposure. As expected, concentrations did not increase linearly with exposure duration due to the fairly rapid clearance of methanol. Clearance half-lives estimated using blood, breath, and urine data were consistent, and the best estimate (1.44 0.33 h) is a meaningful change from the 3-h half-life often cited (e.g., Kavet and Nauss 1990) . Lags in blood concentration with increasing exposure time provide support for a small reservoir or buer for methanol, most likely in the mucous membranes of the respiratory tree. The same reservoir greatly increases breath concentrations for up to 30 min following exposure. Concentrations in blood and urine lag the exposure, and concentrations in urine do not reach levels expected, given the ACGIHrecommended BEI. Although the interpretation of biological samples for short-term exposure is more complex than that for exposure that is relatively constant over a shift, simple ®rst-order models can be used to account for clearance during and following exposure.
